Back to search

Article

T cell correction pipeline for Inborn Errors of Immunity

2024-09-06

Abstract excerpt

CRISPR/Cas9 gene editing technology is a promising tool for correcting pathogenic variants for autologous cell therapies for Inborn Errors of Immunity (IEI). The present IEI correction strategies mainly focus on the knock-in of therapeutic cDNAs, or knockout of the disease-causing gene when feasible. These strategies address many single-gene defects but may disrupt gene expression and require significant optimizat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7c467be-9484-5ae4-978c-7f68dd48bc22
DOI
10.1101/2024.09.03.610811
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
T cell correction pipeline for Inborn Errors of ImmunityDOI 10.1101/2024.09.03.610811
Select a neighboring publication to make it the new centre.